Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

July 2023

DrugPatentWatch reveals NIH funding for patents

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity […]

DrugPatentWatch reveals NIH funding for patents Read Post »

Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook

For IP teams, portfolio managers, R&D leads, and institutional investors who need more than an overview. A pharmaceutical patent is

Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook Read Post »

Make Better Decisions

See Plans & Pricing

Recent Posts

Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked
Why Consumers Pay a “Trust Premium” for Branded Generics
What AI Knows About Your Drug vs. Your Competitors

Popular Posts

CHEMOCENTRYX, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
The Top 10 Longest-Running Drug Patents
Patent Expiration Dates: The Calendar Every Pharmaceutical Investor Watches
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Compounding Pharmacy Patent Strategy: The Complete IP Playbook for 503A, 503B, and the Shortage Market
The Industrialization of Telehealth: A Strategic Analysis of the Ro and Hims & Hers Duopoly
What are the top Biopharmaceutical Business Intelligence Services?
When Blockbusters Fall, Business Development Rises: Win the Patent Cliff
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested